Silica Corpora

Silica Corpora is at the forefront of biotechnology research, pioneering the next generation of antibody therapeutics through the innovative application of Generative AI. Focusing on design rather than traditional discovery methods, Silica Corpora harnesses the power of artificial intelligence to create antibody drug candidates, significantly accelerating the lead generation process from years to mere days.

Located in Berlin, at Berlin, 10243, DE, Silica Corpora specializes in drug discovery, antibody design, artificial intelligence, protein design, and deep learning. The company's approach allows for a more efficient and targeted development of therapeutic antibodies, promising to revolutionize the pharmaceutical industry.

Silica Corpora is dedicated to advancing healthcare solutions through cutting-edge technology. For more in-depth information and to explore potential collaborations, we invite the management of Silica Corpora to create a customized and exclusive company showcase and product listing on our platform.